218 related articles for article (PubMed ID: 15380214)
1. Quinazolinone fungal efflux pump inhibitors. Part 2: In vitro structure-activity relationships of (N-methyl-piperazinyl)-containing derivatives.
Watkins WJ; Lemoine RC; Chong L; Cho A; Renau TE; Kuo B; Wong V; Ludwikow M; Garizi N; Iqbal N; Barnard J; Jankowska R; Singh R; Madsen D; Lolans K; Lomovskaya O; Oza U; Dudley MN
Bioorg Med Chem Lett; 2004 Oct; 14(20):5133-7. PubMed ID: 15380214
[TBL] [Abstract][Full Text] [Related]
2. Quinazolinone-based fungal efflux pump inhibitors. Part 1: Discovery of an (N-methylpiperazine)-containing derivative with activity in clinically relevant Candida spp.
Lemoine RC; Glinka TW; Watkins WJ; Cho A; Yang J; Iqbal N; Singh R; Madsen D; Lolans K; Lomovskaya O; Oza U; Dudley MN
Bioorg Med Chem Lett; 2004 Oct; 14(20):5127-31. PubMed ID: 15380213
[TBL] [Abstract][Full Text] [Related]
3. Quinazolinone fungal efflux pump inhibitors. Part 3: (N-methyl)piperazine variants and pharmacokinetic optimization.
Watkins WJ; Chong L; Cho A; Hilgenkamp R; Ludwikow M; Garizi N; Iqbal N; Barnard J; Singh R; Madsen D; Lolans K; Lomovskaya O; Oza U; Kumaraswamy P; Blecken A; Bai S; Loury DJ; Griffith DC; Dudley MN
Bioorg Med Chem Lett; 2007 May; 17(10):2802-6. PubMed ID: 17350259
[TBL] [Abstract][Full Text] [Related]
4. Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.
Pina-Vaz C; Rodrigues AG; Costa-de-Oliveira S; Ricardo E; Mårdh PA
J Antimicrob Chemother; 2005 Oct; 56(4):678-85. PubMed ID: 16115827
[TBL] [Abstract][Full Text] [Related]
5. Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity.
Borate HB; Sawargave SP; Chavan SP; Chandavarkar MA; Iyer R; Tawte A; Rao D; Deore JV; Kudale AS; Mahajan PS; Kangire GS
Bioorg Med Chem Lett; 2011 Aug; 21(16):4873-8. PubMed ID: 21757344
[TBL] [Abstract][Full Text] [Related]
6. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
[TBL] [Abstract][Full Text] [Related]
7. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
Kurnatowski P; Makieło L; Horwatt-Bozyczko E
Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
[TBL] [Abstract][Full Text] [Related]
8. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
[TBL] [Abstract][Full Text] [Related]
9. Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.
Mai A; Rotili D; Massa S; Brosch G; Simonetti G; Passariello C; Palamara AT
Bioorg Med Chem Lett; 2007 Mar; 17(5):1221-5. PubMed ID: 17196388
[TBL] [Abstract][Full Text] [Related]
10. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
[TBL] [Abstract][Full Text] [Related]
11. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole.
Quan H; Cao YY; Xu Z; Zhao JX; Gao PH; Qin XF; Jiang YY
Antimicrob Agents Chemother; 2006 Mar; 50(3):1096-9. PubMed ID: 16495278
[TBL] [Abstract][Full Text] [Related]
12. Serum repressing efflux pump CDR1 in Candida albicans.
Yang YL; Lin YH; Tsao MY; Chen CG; Shih HI; Fan JC; Wang JS; Lo HJ
BMC Mol Biol; 2006 Jul; 7():22. PubMed ID: 16839415
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimicrobial activity of some 1,5-diaryl-2-methyl-3- carbethoxy-4-(4-methyl-piperazin-1-ylmethyl)-pyrroles and some 1,5-diaryl-2- methyl-3,4-di(4-methyl-piperazin-1-ylmethyl)-pyrroles.
Cerreto F; Scalzo M; Villa A
Farmaco; 1993 Dec; 48(12):1735-46. PubMed ID: 8135996
[No Abstract] [Full Text] [Related]
15. Molecular characterization of fluconazole resistance in a case of Candida albicans ocular infection.
Pancholi P; Park S; Perlin D; Kubin C; Della-Latta P
J Clin Microbiol; 2004 Dec; 42(12):5938-9. PubMed ID: 15583347
[TBL] [Abstract][Full Text] [Related]
16. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
17. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
19. Lipid core nanoparticles as a broad strategy to reverse fluconazole resistance in multiple Candida species.
Domingues Bianchin M; Borowicz SM; da Rosa Monte Machado G; Pippi B; Stanisçuaski Guterres S; Raffin Pohlmann A; Meneghello Fuentefria A; Clemes Külkamp-Guerreiro I
Colloids Surf B Biointerfaces; 2019 Mar; 175():523-529. PubMed ID: 30579053
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antifungal activities of new fluconazole analogues with azaheterocycle moiety.
Lebouvier N; Pagniez F; Duflos M; Le Pape P; Na YM; Le Baut G; Le Borgne M
Bioorg Med Chem Lett; 2007 Jul; 17(13):3686-9. PubMed ID: 17482460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]